{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:28:43Z","timestamp":1790836123938,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009664","name":"Sociedad Espa\u00f1ola de Cardiolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.hlc.2023.01.018","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T15:37:46Z","timestamp":1680881866000},"page":"790-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-4469","authenticated-orcid":false,"given":"Paloma Remior","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn J.","family":"Hylind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5663-4377","authenticated-orcid":false,"given":"Thomas M.","family":"Roston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-6580","authenticated-orcid":false,"given":"Vassilios J.","family":"Bezzerides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-2805","authenticated-orcid":false,"given":"Dominic J.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2023.01.018_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene therapy","volume":"381","author":"High","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hlc.2023.01.018_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCRESAHA.110.226845","article-title":"Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis","volume":"108","author":"Priori","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.hlc.2023.01.018_bib3","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2023.01.018_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.hlc.2018.09.007","article-title":"Channelopathiesthat lead to sudden cardiac death: clinical and genetic aspects","volume":"28","author":"Skinner","year":"2019","journal-title":"Heart Lung Circ"},{"issue":"4","key":"10.1016\/j.hlc.2023.01.018_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hlc.2019.10.013","article-title":"50 years of catecholaminergic polymorphic ventricular tachycardia (CPVT)\u2014time to explore the dark side of the moon","volume":"29","author":"Pflaumer","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"21","key":"10.1016\/j.hlc.2023.01.018_bib6","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.jacc.2020.04.004","article-title":"A\u00a0population-based registry of patients with inherited cardiac conditions and resuscitated cardiac arrest","volume":"75","author":"Rucinski","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.hlc.2023.01.018_bib7","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2017.02.046","article-title":"Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome","volume":"69","author":"Lahrouchi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.hlc.2023.01.018_bib8","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia","volume":"358","author":"Wilde","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hlc.2023.01.018_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hrthm.2015.09.010","article-title":"Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications","volume":"13","author":"Olde Nordkamp","year":"2016","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.hlc.2023.01.018_bib10","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"},{"issue":"11","key":"10.1016\/j.hlc.2023.01.018_bib11","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.hrthm.2021.07.061","article-title":"Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia","volume":"18","author":"Kallas","year":"2021","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.hlc.2023.01.018_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10897-017-0152-1","article-title":"Psychosocial implications of living with catecholaminergic polymorphic ventricular tachycardia in adulthood","volume":"27","author":"Richardson","year":"2018","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.hlc.2023.01.018_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hlc.2023.01.018_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hlc.2023.01.018_bib15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/324565","article-title":"A\u00a0missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholomine-induced polymorphic ventricular tachycardia in Bedouin families from Israel","volume":"69","author":"Lahat","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.hlc.2023.01.018_bib16","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/01.RES.0000038886.18992.6B","article-title":"Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia","volume":"91","author":"Postma","year":"2002","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.hlc.2023.01.018_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ajhg.2012.08.015","article-title":"Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death","volume":"91","author":"Nyegaard","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.hlc.2023.01.018_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"18","key":"10.1016\/j.hlc.2023.01.018_bib19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hlc.2023.01.018_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/heartjnl-2021-320220","article-title":"Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1","volume":"108","author":"Shimamoto","year":"2022","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.hlc.2023.01.018_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10.1016\/j.hlc.2023.01.018_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.hrthm.2015.03.033","article-title":"Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia","volume":"12","author":"Wang\u00fcemert","year":"2015","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.hlc.2023.01.018_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mgg3.1151","article-title":"Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four-generation Canadian family","volume":"8","author":"Tung","year":"2020","journal-title":"Mol Genet Genomic Med"},{"issue":"12","key":"10.1016\/j.hlc.2023.01.018_bib24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41594-020-0510-9","article-title":"The structure of a calsequestrin filament reveals mechanisms of familial arrhythmia","volume":"27","author":"Titus","year":"2020","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"10.1016\/j.hlc.2023.01.018_bib26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/CIRCULATIONAHA.106.623793","article-title":"Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia","volume":"114","author":"Di Barletta","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hlc.2023.01.018_bib27","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.hrthm.2016.05.004","article-title":"A\u00a0novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Gray","year":"2016","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.hlc.2023.01.018_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.120.045723","article-title":"An international multicenter evaluation of inheritance patters, arrhythmic risks, and underlying mechanism of CASQ2-catecholaminergic polymorphic ventricular tachycardia","volume":"142","author":"Ng","year":"2020","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.hlc.2023.01.018_bib29","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","article-title":"Precision medicine in catecholaminergic polymorphic ventricular tachycardia: JACC Focus Seminar 5\/5","volume":"77","author":"Priori","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.hlc.2023.01.018_bib30","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI31080","article-title":"Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia","volume":"117","author":"Song","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.hlc.2023.01.018_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.108.171660","article-title":"Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model","volume":"103","author":"Rizzi","year":"2008","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.hlc.2023.01.018_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.111.263939","article-title":"Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias","volume":"110","author":"Denegri","year":"2012","journal-title":"Circ Res"},{"issue":"25","key":"10.1016\/j.hlc.2023.01.018_bib33","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/CIRCULATIONAHA.113.006901","article-title":"Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age","volume":"129","author":"Denegri","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2023.01.018_bib34","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bpj.2010.06.042","article-title":"So little source, so much sink: requirements for afterdepolarizations to propagate in tissue","volume":"99","author":"Xie","year":"2010","journal-title":"Biophys J"},{"issue":"7","key":"10.1016\/j.hlc.2023.01.018_bib35","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.hrthm.2017.03.025","article-title":"Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models","volume":"14","author":"Kurtzwald-Josefson","year":"2017","journal-title":"Heart Rhythm"},{"issue":"10","key":"10.1016\/j.hlc.2023.01.018_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.304","article-title":"Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Lodola","year":"2016","journal-title":"Cell Death Dis"},{"issue":"10","key":"10.1016\/j.hlc.2023.01.018_bib37","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/01.RES.0000169067.51055.72","article-title":"Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor","volume":"96","author":"Cerrone","year":"2005","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.hlc.2023.01.018_bib38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/CIRCRESAHA.117.310882","article-title":"Allele-specific silencing of mutant mRNA rescues ultrastructural and arrhythmic phenotype in mice carriers of the R4496C mutation in the ryanodine receptor gene (RYR2)","volume":"121","author":"Bongianino","year":"2017","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.hlc.2023.01.018_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/CIRCRESAHA.118.313369","article-title":"In\u00a0Vivo Ryr2 editing corrects catecholaminergic polymorphic ventricular tachycardia","volume":"123","author":"Pan","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2023.01.018_bib40","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.122.320496","article-title":"CRISPR modeling and correction of cardiovascular disease","volume":"130","author":"Liu","year":"2022","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.hlc.2023.01.018_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12975-021-00901-9","article-title":"Calcium\/calmodulin\u2013dependent protein kinase II in cerebrovascular diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Transl Stroke Res"},{"issue":"1","key":"10.1016\/j.hlc.2023.01.018_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2010.10.001","article-title":"Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+\/\u2013) mice with catecholaminergic polymorphic ventricular tachycardia","volume":"50","author":"Liu","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"10","key":"10.1016\/j.hlc.2023.01.018_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.369","article-title":"CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Di Pasquale","year":"2013","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.hlc.2023.01.018_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.119.039711","article-title":"Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.hlc.2023.01.018_bib45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca2+\/calmodulin-dependent kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2023.01.018_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-02735-9","article-title":"We need to ground truth assumptions about gene therapy","author":"Broadfoot","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.hlc.2023.01.018_bib47","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ymthe.2020.01.006","article-title":"Adenovirus\u2013antibody complexes contributed to lethal systemic inflammation in a gene therapy trial","volume":"28","author":"Somanathan","year":"2020","journal-title":"Mol Ther"},{"issue":"13-14","key":"10.1016\/j.hlc.2023.01.018_bib48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/hum.2020.182","article-title":"Moving forward after two deaths in a gene therapy trial of myotubular myopathy","volume":"31","author":"Wilson","year":"2020","journal-title":"Hum Gene Ther"},{"issue":"19","key":"10.1016\/j.hlc.2023.01.018_bib49","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"issue":"569","key":"10.1016\/j.hlc.2023.01.018_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay9648","article-title":"Efficacy and costs of spinal muscular atrophy drugs","volume":"12","author":"Darrow","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1\u20132","key":"10.1016\/j.hlc.2023.01.018_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41434-022-00349-y","article-title":"Curing SMA: are we there yet?","volume":"30","author":"Reilly","year":"2023","journal-title":"Gene Ther"}],"updated-by":[{"DOI":"10.1016\/j.hlc.2025.12.010","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623001105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623001105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:03:25Z","timestamp":1769022205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950623001105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1443950623001105"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2023.01.018","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2023.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}